RM Global Health

www.rmgh.net

 
  • Increase font size
  • Default font size
  • Decrease font size
  • default color
  • green color
  • blue color

Endovascular vs Open Repair of Abdominal Aortic Aneurysms: Any Long-term Difference?

E-mail Print PDF

Endovascular vs Open Repair of Abdominal Aortic Aneurysms in the Medicare Population

Schermerhorn ML, O'Malley J, Jhaveri A, Cotterill P; Pomposelli F; Landon BE
N Engl J Med. 2008;358:464-474

Summary

How does endovascular repair (EVAR) of abdominal aneurysms compare with conventional open repair? The authors reviewed results from 22,830 Medicare patients (average age, 74 years) followed for up to 4 years after they had received either endovascular or open procedures. Early mortality was much lower after endovascular repair: 1.2% vs 4.8%, P < .001). During the follow-up period, the EVAR group had a higher frequency of rupture (1.8% vs 0.5%) and more patients required additional surgery for the graft than those who had the open procedure. However, patients treated with an open repair had more complications related to the abdominal surgery, such as bowel obstruction or abdominal wall hernia, than those who had EVAR. By 4 years, the overall survival in the 2 groups, which initially favored the endovascular group, was identical.

Viewpoint

EVAR for abdominal aortic aneurysms now accounts for about 40% of all of these repair operations. This study, with results extending over a 4-year period, shows an initial overall survival benefit for endovascular repair, which disappears at 4 years. This was not a true randomized study, but the authors attempted to match the 2 groups on factors such as age, sex, race, and coexisting conditions. The results apply only to persons 65 years of age and older; findings might be different in younger patients, with a better survival outlook and an anticipated longer life span. As experience accumulates, the results following EVAR might be expected to improve.



Reviewed By Ramaz Mitaishvili, MD
 
June 15, 2007
Of the 100 cases confirmed to date in Indonesia, 80 have been fatal.

Alerts

VICTORY: Medicare bill becomes law! H.R. 6331 includes SGR fix, Teaching Rule reformIn a historic triumph for ASA, a law has been enacted that will reverse ...
 
Cymbalta® is now approved for fibromyalgia Cymbalta is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) indicated in adults for Acute and mainte...
 
Cymbalta® is now approved for fibromyalgia Cymbalta is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) indicated in adults for Acute and mainte...